自身抗体反应组分析揭示特发性腹膜后纤维化新型生物标志物
本研究纳入33例特发性腹膜后纤维化(iRPF)患者、100例健康对照、11例腹膜后肉瘤(RPS)及74例其他自身免疫病患者,用蛋白阵列筛选自身抗体并经ELISA和斑点印迹验证。发现抗RBPJ、TPM1、C1D、NPM1和IL-1A抗体在iRPF中显著升高,其中抗TPM1与肾积水严重程度和血肌酐正相关且治疗后下降,抗C1D可区分iRPF与RPS(AUC=0.718)。
要点
- 抗TPM1抗体与肾积水严重程度(P<0.05)和血肌酐(P<0.01)正相关,治疗后下降。
- 抗C1D抗体可区分iRPF与腹膜后肉瘤(P<0.01,AUC=0.718)。
- 抗RBPJ抗体治疗后升高(P<0.01)且与IL-6负相关(P<0.05),可能为保护性抗体。
核心结论
- 研究识别出五种对iRPF具有诊断潜力的自身抗体,为早期检测、疾病监测和机制研究提供新依据。
研究设计与样本
- 研究纳入33例iRPF患者、100例健康对照、11例RPS和74例其他自身免疫病患者,来源为仁济医院2018年1月至2025年4月。
- 使用Sengenics Immunome蛋白阵列筛选自身抗体,并通过ELISA和斑点印迹验证其表达及IgG4亚类。
- 采用Pearson相关和ROC曲线分析结合临床参数评估诊断性能。
主要发现
- iRPF患者血浆中抗RBPJ、TPM1、C1D、NPM1和IL-1A自身抗体水平较健康对照显著升高。
- 抗TPM1抗体水平与肾积水严重程度(P<0.05)和血清肌酐浓度(P<0.01)正相关,且治疗后下降。
- 抗RBPJ抗体治疗后升高(P<0.01)并与IL-6负相关(P<0.05)。
- 抗C1D抗体区分iRPF与RPS的P<0.01、AUC=0.718,其IgG4亚类与Th1/Th2失衡及肾功能损害相关。
- 抗NPM1 IgG4/IgG比值与肾损伤标志物和Th2型细胞因子正相关。
关键数值与推荐
- 抗C1D抗体区分iRPF与RPS的AUC=0.718(P<0.01)。
- 抗TPM1与肾积水严重程度相关P<0.05,与血清肌酐相关P<0.01。
- 抗RBPJ治疗后升高P<0.01,与IL-6负相关P<0.05。
临床怎么用
- 抗TPM1抗体或可作为iRPF肾损伤和疾病活动的生物标志物,用于监测病情。
- 抗C1D抗体有助于iRPF与腹膜后肉瘤的鉴别诊断。
- 抗RBPJ抗体可能反映保护性免疫,治疗后升高提示其潜在保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Idiopathic retroperitoneal fibrosis (iRPF) is a rare disease frequently misdiagnosed due to the lack of reliable biomarkers. This study aimed to identify novel autoantibodies to improve the diagnosis and differential diagnosis of iRPF. METHODS: A total of 33 patients with iRPF, 100 healthy controls, 11 with retroperitoneal sarcoma (RPS) and 74 with other autoimmune diseases were recruited from Renji Hospital from January 2018 to April 2025. Autoantibodies were screened using the Sengenics Immunome Protein Array. Their expression and particularly their IgG4 subclass were then validated by enzyme-linked immunosorbent assay (ELISA) and dot blot assays. Pearson correlation and receiver operating characteristic (ROC) curve analyses were performed with clinical parameters to evaluate their diagnostic performance. RESULTS: Plasma levels of autoantibodies targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ), tropomyosin alpha-1 (TPM1), nuclear nucleic acid-binding protein (C1D), nucleophosmin 1 (NPM1) and interleukin-1α (IL-1A) were significantly elevated in iRPF patients compared with healthy controls. Among these, anti-TPM1 antibody levels positively correlated with hydronephrosis severity (P < 0.05) and serum creatinine concentrations (P < 0.01), and declined after treatment, suggesting their potential as biomarkers of renal injury and disease activity. Anti-RBPJ antibodies increased after treatment (P < 0.01) and showed a negative correlation with IL-6 (P < 0.05), suggesting the potential for protective antibodies. Anti-C1D antibodies distinguished iRPF from RPS (P < 0.01, AUC = 0.718), and their IgG4 subclass was associated with a Th1/Th2 imbalance and renal impairment. Anti-NPM1 IgG4/IgG ratio was positively correlated with renal injury markers and Th2-type cytokines. CONCLUSION: This study identified five autoantibodies with diagnostic potential for iRPF, providing a novel basis for early detection, disease monitoring and further mechanistic investigations.
引用
- He X, Ouyang L, Meng X, et al. Autoantibody reactome analysis reveals novel biomarkers for idiopathic retroperitoneal fibrosis. Rheumatology (Oxford). 2026. PMID: 42049967. doi:10.1093/rheumatology/keag210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。